Comparison of lamivudine and alpha-interferon combination with alpha-interferon alone in the treatment of HBeAg-positive chronic hepatitis B

Indian Journal of Gastroenterology

Volumn 25, Issue 2, 2006, Pages 71-73

  Ayaz, Celal ^a   Celen, Mustafa Kemal ^a   Colak, Habibe ^a   Hosoglu, Salih ^a   Geyik, Mehmet Faruk ^a  

^a DICLE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHA INTERFERON PLUS LAMIVUDINE; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; UNCLASSIFIED DRUG; ALPHA2A INTERFERON; ANTIVIRUS AGENT;

AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DRUG EFFICACY; HEMATOLOGIC DISEASE; HEPATITIS B; HUMAN; MAJOR CLINICAL STUDY; RANDOMIZED CONTROLLED TRIAL; SEROCONVERSION; ADULT; BLOOD; COMPARATIVE STUDY; DRUG COMBINATION; FEMALE; MALE; TREATMENT OUTCOME;

ADULT; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HEPATITIS B E ANTIGENS; HEPATITIS B, CHRONIC; HUMANS; INTERFERON ALFA-2A; LAMIVUDINE; MALE; TREATMENT OUTCOME;

EID: 33746924886     PISSN: 02548860     EISSN: 02548860     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Yao F, Gish RG. Treatment of chronic hepatitis B: new antiviral therapies. Curr Gastroenterol Rep 1999;1:20-6.
2. Gurkan F, Kocak N, Ozen H, Yuce A. Comparison of standard and high dosage recombinant interferon alpha 2b for treatment of children with chronic hepatitis B infection. Pediatr Infect Dis J 2000;19:52-6.
3. Yalcin K, Degertekin H, Yildiz F, Celik Y. Comparison of 12-month courses of interferon alpha-2b-lamivudine combination therapy and interferon alpha-2b monotherapy among patients with untreated chronic hepatitis B. Clin Infect Dis 2003;36:1516-22.
4. Wong DKH, Cheung AM, O'Rourke K, Naylor CD, Detsky AS, Heathcote J. Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. Ann Intern Med 1993;119:312-23.
5. Nevens F, Main J, Honkoop P, Tyocell DL, Baber J, Sullivan MT, et al . Lamivudine therapy for chronic hepatitis B: a six-month randomized dose-ranging study. Gastroenterology 1997;113;1258-63.
6. Dikici B, Bosnak M, Bosnak V, Dugli A, Davutoglu M , Yogci RV , et al . Comparison of treatments of chronic hepatitis B in children with lamivudine and a-interferon combination and a-interferon alone. Pediatr Int 2002;44:517-21.
7. Dienstag JL, Schiff ER, Wright TL, Perrillo RP, Hann HW, Goodman Z, et al . Lamivudine as initial treatment for chronic hepatitis B in the United States. N Engl J Med 1999;341:1256-63.
8. Lai CL, Chien RN, Leung NW, Chang TT, Guan R, Tai DI, et al . A one year trial of lamivudine for chronic hepatitis B. N Engl J Med 1998;339:61-8.
9. Thakur V, Sarin SK, Rehman S, Guptan RC, Kazim SM, Kumar S, et al . Role of HBV genotype in predicting response to lamivudine therapy in patients with chronic hepatitis B. Indian J Gastroenterol 2005;24:12-5.
10. Mutimer D, Dowling D, Cane P, Ratcliffe D, Tharoj H, O'Donnell K, et al . Additive antiviral effects of lamivudine and a-interferon in chronic hepatitis B infection. Antivir Ther 2000;5:273-7.
11. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al . Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431-5.
12. Seehofer D, Rayes N, Berg T, Neuhaus R, Muller AR, Hopf U, et al . Additional interferon alpha for lamivudine resistant hepatitis B infection after liver transplantation: a preliminary report. Transplantation 2000;69:1739-42.
13. Schalm SW, Heathcote J, Cianciara J, Farrell GC, Sherman M, Williams B, et al . Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomised trial. Gut 2000;46:562-8.
14. Janssen HL, Gerken G, Carreno V, Marcellin P, Naoumov NO, Craxi A, et al . Interferon alpha for chronic hepatitis B infection: increased efficacy of prolonged treatment. Hepatology 1999;30:238-43.